MedTrace Logo

Systemic Therapies for Pediatric Atopic Dermatitis

NCT01447381 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2012-11-05

No results posted yet for this study

Summary

While many patients with atopic dermatitis (eczema) can be managed with topical creams and treatments for itch, some children have such severe, long-standing disease that they need treatment with oral medications that decrease the ability of the immune system to react. However, there is not enough information on the proper use of these medications or how well they work compared with each other. The current study looks at the response of children treated with these medications to provide this information and improve their use.

Conditions

  • Dermatitis, Atopic

Sponsors & Collaborators

Principal Investigators

  • Wynnis Tom, MD · Rady Children's Hospital and UC San Diego

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01447381 on ClinicalTrials.gov